Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162492372> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2162492372 endingPage "1615" @default.
- W2162492372 startingPage "1606" @default.
- W2162492372 abstract "<h2>Abstract</h2><h3>Purpose</h3> The purpose of this study was to assess the effect of renal impairment on the pharmacokinetic, pharmacodynamic, and safety profiles of empagliflozin, a sodium glucose cotransporter 2 <b>(</b>SGLT2) inhibitor, in Japanese patients with type 2 diabetes mellitus (T2DM). <h3>Methods</h3> In an open-label, parallel-group study, 32 Japanese patients with T2DM and different degrees of renal function (n = 8 per renal function category: normal renal function, estimated glomerular filtration rate [eGFR; Japanese equation] ≥90 mL/min/1.73 m<sup>2</sup>; mild renal impairment, eGFR of 60–<90 mL/min/1.73 m<sup>2</sup>; moderate renal impairment, eGFR of 30–<60 mL/min/1.73 m<sup>2</sup>; and severe renal impairment, eGFR of 15–<30 mL/min/1.73 m<sup>2</sup>) received a single 25 mg dose of empagliflozin. <h3>Findings</h3> Empagliflozin exposure increased with increasing renal impairment. Maximum empagliflozin plasma concentrations were similar among all renal function groups. Adjusted geometric mean ratios for extent of exposure (AUC<sub>0–∞</sub>) to empagliflozin versus normal renal function were 128.8% (95% CI, 106.0–156.6%), 143.8% (95% CI, 118.3–174.8%), and 152.3% (95% CI, 125.3–185.2%) for patients with mild, moderate, and severe renal impairment, respectively. Decreases in renal clearance of empagliflozin correlated with eGFR. Urinary glucose excretion decreased with increasing renal impairment and correlated with eGFR (adjusted mean [SE] change from baseline: 75.0 [4.84] g, 62.6 [5.75] g, 57.9 [4.86] g, and 23.7 [5.24] g for patients with normal renal function and mild, moderate, and severe renal impairment, respectively). Only 2 patients (6%) had adverse events; both were mild. <h3>Implications</h3> Pharmacokinetic data suggest that no dose adjustment of empagliflozin is necessary in Japanese patients with T2DM and renal impairment because increases in exposure were <2-fold. Urinary glucose excretion decreased with increasing renal impairment. ClinicalTrials.gov identifier: NCT01581658." @default.
- W2162492372 created "2016-06-24" @default.
- W2162492372 creator A5009952197 @default.
- W2162492372 creator A5012223927 @default.
- W2162492372 creator A5036322140 @default.
- W2162492372 creator A5043462775 @default.
- W2162492372 creator A5046420484 @default.
- W2162492372 creator A5054243155 @default.
- W2162492372 creator A5070460587 @default.
- W2162492372 creator A5073988431 @default.
- W2162492372 creator A5080582585 @default.
- W2162492372 creator A5088439699 @default.
- W2162492372 date "2014-11-01" @default.
- W2162492372 modified "2023-10-03" @default.
- W2162492372 title "Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Japanese Patients With Type 2 Diabetes Mellitus" @default.
- W2162492372 cites W1945535054 @default.
- W2162492372 cites W1994679938 @default.
- W2162492372 cites W2001963088 @default.
- W2162492372 cites W2075224373 @default.
- W2162492372 cites W2090979363 @default.
- W2162492372 cites W2097132878 @default.
- W2162492372 cites W2105028010 @default.
- W2162492372 cites W2128219379 @default.
- W2162492372 cites W2134855422 @default.
- W2162492372 cites W2151209197 @default.
- W2162492372 cites W2152189242 @default.
- W2162492372 cites W2153336680 @default.
- W2162492372 cites W2169403426 @default.
- W2162492372 cites W2172193326 @default.
- W2162492372 doi "https://doi.org/10.1016/j.clinthera.2014.08.001" @default.
- W2162492372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25199997" @default.
- W2162492372 hasPublicationYear "2014" @default.
- W2162492372 type Work @default.
- W2162492372 sameAs 2162492372 @default.
- W2162492372 citedByCount "26" @default.
- W2162492372 countsByYear W21624923722015 @default.
- W2162492372 countsByYear W21624923722016 @default.
- W2162492372 countsByYear W21624923722017 @default.
- W2162492372 countsByYear W21624923722018 @default.
- W2162492372 countsByYear W21624923722020 @default.
- W2162492372 countsByYear W21624923722022 @default.
- W2162492372 countsByYear W21624923722023 @default.
- W2162492372 crossrefType "journal-article" @default.
- W2162492372 hasAuthorship W2162492372A5009952197 @default.
- W2162492372 hasAuthorship W2162492372A5012223927 @default.
- W2162492372 hasAuthorship W2162492372A5036322140 @default.
- W2162492372 hasAuthorship W2162492372A5043462775 @default.
- W2162492372 hasAuthorship W2162492372A5046420484 @default.
- W2162492372 hasAuthorship W2162492372A5054243155 @default.
- W2162492372 hasAuthorship W2162492372A5070460587 @default.
- W2162492372 hasAuthorship W2162492372A5073988431 @default.
- W2162492372 hasAuthorship W2162492372A5080582585 @default.
- W2162492372 hasAuthorship W2162492372A5088439699 @default.
- W2162492372 hasConcept C111113717 @default.
- W2162492372 hasConcept C112705442 @default.
- W2162492372 hasConcept C126322002 @default.
- W2162492372 hasConcept C126894567 @default.
- W2162492372 hasConcept C134018914 @default.
- W2162492372 hasConcept C159641895 @default.
- W2162492372 hasConcept C161457703 @default.
- W2162492372 hasConcept C2775887513 @default.
- W2162492372 hasConcept C2910068830 @default.
- W2162492372 hasConcept C555293320 @default.
- W2162492372 hasConcept C71924100 @default.
- W2162492372 hasConcept C98274493 @default.
- W2162492372 hasConceptScore W2162492372C111113717 @default.
- W2162492372 hasConceptScore W2162492372C112705442 @default.
- W2162492372 hasConceptScore W2162492372C126322002 @default.
- W2162492372 hasConceptScore W2162492372C126894567 @default.
- W2162492372 hasConceptScore W2162492372C134018914 @default.
- W2162492372 hasConceptScore W2162492372C159641895 @default.
- W2162492372 hasConceptScore W2162492372C161457703 @default.
- W2162492372 hasConceptScore W2162492372C2775887513 @default.
- W2162492372 hasConceptScore W2162492372C2910068830 @default.
- W2162492372 hasConceptScore W2162492372C555293320 @default.
- W2162492372 hasConceptScore W2162492372C71924100 @default.
- W2162492372 hasConceptScore W2162492372C98274493 @default.
- W2162492372 hasFunder F4320310441 @default.
- W2162492372 hasIssue "11" @default.
- W2162492372 hasLocation W21624923721 @default.
- W2162492372 hasLocation W21624923722 @default.
- W2162492372 hasOpenAccess W2162492372 @default.
- W2162492372 hasPrimaryLocation W21624923721 @default.
- W2162492372 hasRelatedWork W1758514097 @default.
- W2162492372 hasRelatedWork W1850703972 @default.
- W2162492372 hasRelatedWork W1994679938 @default.
- W2162492372 hasRelatedWork W2010116591 @default.
- W2162492372 hasRelatedWork W2113143771 @default.
- W2162492372 hasRelatedWork W2127396703 @default.
- W2162492372 hasRelatedWork W2162492372 @default.
- W2162492372 hasRelatedWork W2227061539 @default.
- W2162492372 hasRelatedWork W2594910449 @default.
- W2162492372 hasRelatedWork W2992709639 @default.
- W2162492372 hasVolume "36" @default.
- W2162492372 isParatext "false" @default.
- W2162492372 isRetracted "false" @default.
- W2162492372 magId "2162492372" @default.
- W2162492372 workType "article" @default.